Business
My Size, Inc. Prices $1.75 Million Underwritten Public Offering of Common Stock
Airport City, Israel, Jan. 05, 2021 (GLOBE NEWSWIRE) -- My Size, Inc. (the "Company" or "My Size") (NASDAQ: MYSZ) (TASE: MYSZ), a developer of
About this update from My Size, Inc.
[{"type":"text","content":" Airport City, Israel, Jan. 05, 2021 (GLOBE NEWSWIRE) -- My Size, Inc. (the \"Company\" or \"My Size\") (NASDAQ: MYSZ) (TASE: MYSZ), a developer of smartphone-based measurement solutions, today announced the pricing of an underwritten public offering with gross proceeds to the Company expected to be approximately $1.75 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. The proposed offering equates to 1,364,503 shares of the Company’s common stock at a price of $1.28 per share. The Company intends to use the net proceeds from this offering for working capital and general corporate purposes. The Company has also granted the underwriters a 45-day option to purchase up to an additional 15% of the number of shares of common stock offered in the public offering to cover over-allotments, if any, at the public offering price. The offering is expected to close on or about January 8, 2020, subject to customary closing conditions. Aegis Capital Corp. is acting as sole bookrunner for the offering. This offering is being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-251679) previously filed with the U.S. Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on December 30, 2020. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus, when available, may be obtained by contacting Aegis Capital Corp., Attention: Syndicate Department, 810 7th Avenue, 18th floor, New York, NY 10019, by email at [email protected], or by telephone at (212) 813-1010. Before investing in this offering, interested parties should read in their entirety the prospectus supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisd...